Avoro Capital Advisors LLC reports

Company location: New York, NY
Fiscal year end: 31 December

Avoro Capital Advisors LLC has filed 312 SEC EDGAR filings since 13 Feb 2015

Filter by type:
SC13D
SC13G

SEC filing history

Showing 101-125 of 312 matching filings.

Per page

Current page

SC 13G/A

MERSANA THERAPEUTICS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MADRIGAL PHARMACEUTICALS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

IVERIC BIO, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

KYMERA THERAPEUTICS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

APELLIS PHARMACEUTICALS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MARINUS PHARMACEUTICALS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AMICUS THERAPEUTICS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

PMV PHARMACEUTICALS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

UNITED THERAPEUTICS CORPORATION

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MIRATI THERAPEUTICS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

KRYSTAL BIOTECH, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

ASCENDIS PHARMA A/S

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KURA ONCOLOGY, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

DICE THERAPEUTICS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

IOVANCE BIOTHERAPEUTICS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ADVERUM BIOTECHNOLOGIES, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-16573

13F-HR filing

Filing date: 14 Feb 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-36500

4 filing

Filing date: 30 Jan 2023
Reporting date: 26 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-16573

13F-HR filing

Filing date: 14 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-38560

4 filing

Filing date: 26 Sep 2022
Reporting date: 22 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

AADI BIOSCIENCE, INC.

Filing date: 26 Sep 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-16573

13F-HR filing

Filing date: 15 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-38560

FORM 4 SUBMISSION

Filing date: 17 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-16573

13F-HR filing

Filing date: 16 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-16573

13F-HR filing

Filing date: 14 Feb 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing